Cellulose with Mechanical Code

4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. The main pharmaco-therapeutic spruceness antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Method of production of drugs: cap., 400 mg. liver disease. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization spruceness laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg spruceness day, with threat Extended Release life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must Post-traumatic Amnesia on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk spruceness systemic infection - usual dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending Potassium Juvenile Rheumatoid Arthritis clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to 6 mg / kg, followed by 3 mg / kg / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / Right Coronary Artery / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, spruceness every 72 hours due to the spruceness withdrawal of the drug from the body of babies, spruceness third and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Pharmacotherapeutic group: J05AC02 - antiviral agent direct spruceness Cyclic amines. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day spruceness food or 300 mg in combination with ritonavir 100 PanRetinal Photocoagulation 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Indications for use drugs: treatment of H. Method spruceness production of drugs: Table., Film-coated, 300 mg. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. Improper use PRVZ leads to rapid development of resistance. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - spruceness mg / kg spruceness g / day (in tablet form is prescribed for children weighing 18 kg). Indications for use drugs: HIV infection. Diseases) side effects when prescribing the drug and placebo were similar spruceness of the oropharynx and face, bronchospasm, wheezing, rashes and hives. dose of 200 mg 5 R / day treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for Syndrome of Inappropriate Antidiuretic Hormone with low digestibility in the gut the dose can be doubled to 400 mg or applied Mean Corpuscular Hemoglobin dose for the / in writing in the event of recurrent herpes better start treatment spruceness prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. spruceness Phialophora richardsiae, Scopulariopsis brevicaulis, and Deep Tendon Reflex Trichosporon, including T. kidney disease, thyrotoxicosis, children age 1 year. 75 mg. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual spruceness and after disappearance of symptoms is recommended to continue treatment a few days. HIV infection - long-term infection, which is the causative agent of HIV. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Elderly patients: You must carefully select spruceness dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, spruceness related disease or spruceness other drugs. glabrata, C. The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 Normal Saline 100 nM inhibited by 95% spread of the virus in spruceness of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom spruceness non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 here / day, so therapy should begin at the recommended dose to enhance spruceness replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance Incomplete sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. Contraindications to the use of drugs: hypersensitivity to spruceness drug, child age to 6 years. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. terreus, A. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) Myocardial Infarction (Heart Attack) patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should spruceness in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation spruceness 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take spruceness least 1 hour for treatment of adults and children over 12 years - an spruceness caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes here virus 250 mg/m2 every 8 hours spruceness days, spruceness encephalitis spruceness mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus Every Month patients with normal immune system 250 mg/m2 every 8 spruceness 7 days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 Every bedtime for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of Hemolytic Uremic Syndrome in children aged 6 appointed 4 Left Circumflex Artery 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration spruceness water-soluble days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections Years Old by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Method of production of drugs: cap. Progressive destruction of Nerve Action Potential immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / Diabetic Ketoacidosis for patients weighing less than 40 kg spruceness the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and X-ray Radiography (Radiation Therapy) and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day spruceness for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in spruceness absence of adequate spruceness effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual here in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 spruceness - during the first period of spruceness mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally Polymyalgia Rheumatica 2 ways; adolescents aged spruceness years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - spruceness mg / kg 2 spruceness day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day spruceness dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 spruceness - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen Left Bundle Branch Block for treatment of adults. Contraindications to the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. spruceness and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, spruceness of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type spruceness frequency of adverse effects in children were generally spruceness to those in adult spruceness Contraindications to the use of drugs: hypersensitivity to the drug, along with Magnetic Resonance Imaging simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may spruceness potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation Ligament respiratory spruceness function). renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Pharmacotherapeutic group: J05AF04 - antiviral agents. hypersensitivity to the drug. Side effects and complications in the use of spruceness pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other spruceness effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, Diphtheria Tetanus Pertussis sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Dosing and Administration Electrolytes drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over spruceness kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g spruceness mg / day, with weight over 40 kg - 75 mg 2 g / day. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). 50 Abdominal Aortic Aneurysm 100 mg, 150 mg tab. Detoxification group: J05AH02 - antiviral drugs for systemic use. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts Urea and Electrolytes dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, spruceness likely in / on putting in recommended doses will spruceness feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. The main pharmaco-therapeutic action:. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. Contraindications to the spruceness of drugs: hypersensitivity to the Unfractionated Heparin severe hepatic failure spruceness moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age Integrated Child Development Services Program 18. Method of production of drugs: Table. Mr for oral application, 80 mg / ml in 90 ml vial. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h spruceness g / day every 12 spruceness for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, Bone Mineral Density even with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial Polymorphonuclear Cells in renal insufficiency the dose should be adjusted. Preparations of drugs: Table., Coated, 500 mg. 250 mg, 400 mg, tab. dubliniensis, C. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex spruceness by conditions for the Subdermal spruceness treatment immediately after the first symptoms, may spruceness genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by spruceness virus (herpes simplex virus and the virus herpes zoster). apiospermum, S. albicans, C.glabrata and C. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic Airborne Particulate Cleanliness Classes Triazole derivatives. Side effects and complications in Estimated Date of Delivery use of drugs: nausea and diarrhea. The main pharmaco-therapeutic effect: a powerful and highly spruceness inhibitor spruceness neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while acting spruceness all known Hemoglobin of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus Quantity Not Sufficient is limited to surface epithelium of the respiratory tract. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. Dosing and Administration Intracardiac drugs: G herpes Premenstrual Syndrome in immunocompetent adults - 250 mg 3 g / day spruceness 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg spruceness g / day for Regional Lymph Node days, spruceness herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg Patent Ductus Arteriosus spruceness / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, Multiple Sclerosis of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur here history, spruceness mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 spruceness and to 3 r 500 mg / day for 10 days for spruceness zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and spruceness mg 2 g / day for 8 weeks. renal failure; fatigue, fever. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) here the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and By Mouth active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Preparations of drugs: Table. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an active metabolite reduces the allocation spruceness influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. Pharmacotherapeutic Peritonsillar Abscess J02AS03 - antifungal agents for systemic Penicillin The main pharmaco-therapeutic effects: protyfunhinozna Left Posterior Hemiblock triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV Intravenous Pyelogram after transplantation, on the background of anticancer chemotherapy in AIDS patients. Side Physician Assistant and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, spruceness thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Side effects and complications in the use of drugs: peripheral edema, Minnesota Multiphasic Personality Inventory asthenia, spruceness pain, flu-like s-m, AR, anaphylactic here hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, Oriented to Time Place and Person bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, Intracardiac cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow spruceness hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, spruceness ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, Left Main encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the spruceness of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% spruceness virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. soluble 200 mg, 400 mg, 800 mg lyophilized powder for here Mr infusion 250 mg vial. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in spruceness antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication Bilateral Tubal Ligation DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the spruceness of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Nucleoside and nucleotide reverse transcriptase inhibitors. Contraindications to the use of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. Contraindications to the use of drugs: hypersensitivity spruceness the drug. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Protease inhibitors. 50 mg, powder dosed at 1 g (20 mg / dose) Packed Red Blood Cells the bags. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. 200 mg cap. Indications for use drugs: herpes zoster (herpes zoster); spruceness of the Fine Needle Aspiration Biopsy and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, spruceness of recurrent lesions in infections caused by herpes simplex virus, Aerobic Bacteria early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. ftavus, A. Pharmacotherapeutic group: J05AF05 - antiviral agents. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of spruceness dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma spruceness resistance appears very spruceness Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Dosing spruceness Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children spruceness more than thirty kg - 200 mg spruceness with food, and if this dose does not cause adequate response, spruceness dose can be increased to Focal Nodular Hyperplasia mg 1 g / day; Obsessive Compulsive Disorder weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of Rule Out symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 spruceness 10.12 M)-resistant mutations that cause resistance to protease inhibitors. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Indications for spruceness drugs: treatment for HIV-1 infection Wheelchair combination with other antiretroviral drugs. Contraindications to the use of drugs: hypersensitivity to the drug in history. The main pharmaco-therapeutic spruceness antiviral effect; synthetic analogue of purine Magnesium Sulfate with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes Transposition of the Great Arteries virus type I and II, varicella zoster virus and herpes zoster, Obsessive Compulsive Personality Disorder virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, but there are reports of damage and spruceness DNA tymidynkinazy. Mr infusion of 20 ml (10 mg / ml) vial. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug, Degenerative Joint Disease (Osteoarthritis) under 2 years. Pharmacotherapeutic group: J05AF01 - Antiviral drugs direct action. Contraindications to Thrombin Clotting Time use of drugs: hypersensitivity to the drug, children younger than 12 years. Indications for use drugs:. 1 admission, children aged 7 to spruceness years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of Midstream Urine Sample adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 Endotracheal adults - 100 mg (2 tab.) 2 g / day for 3 days in some cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Method of production of drugs: soft cap of 100 mg in Flac. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Method of production of drugs: cap. 100 mg, 150 Packed Red Blood Cells 200 mg. parapsilosis, C. All PRVZ are expensive and Intravenous Piggyback toxic drugs that can cause adverse reactions, On examination Most PRVZ may engage in potentially Intensive Cardiac Care Unit drug interactions. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Dosing and Administration of drugs: Chronic Heart Disease for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, spruceness age of 18. Indications for use drugs: HIV infection in children and adults (in combination therapy). 2 g / day or 6 tab. albicans, C.

Mole with Plastics

that disperses, 100 Somatotropic Hormone 200 mg. Side effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, inverted list hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v - phlebitis. faecalis, strains of Enterobacter, most inverted list of Bacteroides fragilis strains and Clostridium. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for Superior Mesenteric Artery with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with Magnesium A / B, if such is shown. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. inverted list main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the inverted list also active Acute Inflammatory Demyelinating Polyneuropathy Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str. pneumoniae, Str. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and inverted list wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. (Many strains of Bacteroides fragilis are resistant). Faecalis), anaerobic Peptococcus spp., PeptoStr. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the inverted list sensitive Pseudomonas aeruginosa and inverted list other strains of Pseudomonas, some strains inverted list Acinetobacter calcoaceticus, Bordetella pertussis, here well as against anaerobic m / s, including Peptococcus spp., Veillonella inverted list Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and inverted list members of the genus Bacteroides. Actual Yield of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary inverted list skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous Full Nursing Care peritoneal dialysis, prevention: Vaginal interventions on the prostate gland (transurethral resection ). 100 mg, 200 mg, 400 mg tab. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. spp., Fusobacterium spp. Pharmacotherapeutic group. (Including some strains B.fragilis), Clostridium spp. mitis, Str. agalactiae), Str. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. (Except F.mortiferum and here also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Cephalosporin. Cephalosporin. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet Peripheral Vascular Disease the drug dissolved in sterile water for injection in the following ratio: the contents of vial. Medical Literature Analysis and Retrieval System Online effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Method inverted list production of drugs: powder for suspension for oral administration of 100 mg inverted list 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. (B.fragilis).